What Dolphin Sutures does

Dolphin Sutures (legal entity Futura Surgicare Pvt. Ltd.) is a Bangalore, India-based manufacturer of surgical sutures and adjacent wound closure products, founded in 1994 and exporting to over 80 countries. The company operates a single Class 10,000 cleanroom manufacturing facility with in-house ETO sterilization and an integrated Quality Control Laboratory, producing both absorbable sutures (Polyglycolic Acid, Polyglactin 910, Polydioxanone, Poliglecaprone 25, Catgut) and non-absorbable sutures (Polypropylene, Nylon, Polyester, Silk, Stainless Steel), plus specialty lines (Triclosan-coated antibacterial sutures, PTFE/Teflene, UHMWPE/Durafibr, knotless barbed Durabarb) and complementary wound closure devices including surgical mesh, disposable and reusable skin staplers, mesh tackers, polymer clips, ORC-based absorbable hemostats, bone wax, surgical tapes, and procedure-specific suture kits.

The company sells to three primary segments: surgeons and surgical specialists across cardiothoracic, orthopedic, ophthalmic, cardiovascular, and general surgery; hospitals and healthcare facilities including government and defence establishments; and an international distributor network covering 80+ countries across Africa, Asia, Europe, Australia, and South America. Go-to-market is enterprise B2B field sales for domestic hospital accounts combined with a distributor-heavy export model, supplemented by OEM/private label manufacturing services for partners marketing products under their own brands. The company carries a comprehensive regulatory stack—CE Class 2B and Class 3, ISO 13485, ISO 9001, WHO GMP, Indian FDA, ICMED, GLP—and claims multiple Indian industry firsts, including the introduction of synthetic absorbable sutures in 1997, Triclosan-coated antibacterial sutures, PTFE sutures, and knotless barbed sutures.

Revenue mechanics are quote-based B2B with volume discounting and OEM customization, pricing not publicly disclosed. The company is privately held with no disclosed revenue or financial statements; the most recent material event is a $25 million Series 4 funding round led by Jashvik Capital in June 2024. Distribution expansion and product line extensions into mesh fixation (TACKSURE), hemostats (Hemostax), and polymer clips (POLYLOC) indicate ongoing portfolio diversification beyond sutures into the broader surgical wound closure and adjunctive device market.

Name

Dolphin Sutures

Legal name

Futura Surgicare Pvt. Ltd.

Website

https://dolphinsutures.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

251–500 employees

Short description

Dolphin Sutures (Futura Surgicare Pvt. Ltd.) is a Bangalore-based manufacturer of surgical sutures and wound closure products exporting to 80+ countries. The company serves surgeons, hospitals, and international distributors with absorbable, non-absorbable, antibacterial, and specialty sutures plus mesh and staplers.

Ownership category

akta.pro rank

Product category

Surgical Sutures and Wound Closure Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Wound Closure & Securement (Sutures, Staples, Tissue Adhesives, Skin Closure Strips) (HLAHALAD)

akta.pro secondary industry

Wound & Ostomy Skin Care (Barrier Films/Creams, Adhesive Removers, Cleansers) (HLAHALAK)

Keywords

• Surgical sutures
• Wound closure devices
• Surgical mesh products
• Medical device manufacturing
• Absorbable sutures

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Surgical Sutures Sales: Primary revenue from manufacturing and selling surgical sutures including absorbable (PGA, Polyglactin 910, Polydioxanone, Poliglecaprone, Catgut) and non-absorbable (Polypropylene, Nylon, Polyester, Silk, Steel) sutures. Products sold to hospitals, surgeons, and distributors globally.
2. Wound Closure Products: Diversified product portfolio including surgical mesh, skin staplers (Dermamate, Duramate), bone wax, surgical tapes, hemostats, and suture kits for specialized surgeries (Hernia, Caesarean, Orthopaedic, OB Gyn).
3. OEM/Private Label Manufacturing: Licensed to manufacture and supply products under private label or neutral label as per customer requirements. Offers CE certified OEM products for international partners and distributors.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Dolphin Sutures (Futura Surgicare Pvt. Ltd.) manufactures and globally exports surgical sutures and wound closure devices from its Bangalore facility. The product portfolio covers absorbable and non-absorbable sutures across multiple material chemistries (PGA, Polyglactin 910, Polydioxanone, Poliglecaprone, Catgut, Polypropylene, Nylon, Polyester, Silk, Steel), specialty sutures (Triclosan-coated antibacterial, PTFE, UHMWPE, knotless barbed), and adjacent wound closure products including surgical mesh, skin staplers, mesh tackers, polymer clips, hemostats, bone wax, and customized procedure suture kits. Products are sold to hospitals, surgeons, distributors in 80+ countries, and OEM/private label partners.

Product overview

Dolphin Sutures (Futura Surgicare Pvt. Ltd.) is a comprehensive wound closure products manufacturer and exporter based in Bangalore, India, established in 1994. The company offers a unified portfolio of surgical sutures and wound closure devices organized across multiple product lines. Core sutures include absorbable options (PETCRYL PGA, PETCRYL 910 Polyglactin, PETCRYL MONO Poliglecaprone, DURACRYL Polydioxanone, PROGUT Catgut) and non-absorbable options (DURACARE Polypropylene, LINEX Nylon, PROCARE Polyester, SUTURA Silk, Steel Sutures). Specialty sutures feature Antibacterials (Triclosan-coated), TEFLENE PTFE, DURAFIBR UHMWPE, and Durabarb knotless barbed sutures. Adjacent wound closure products include Dolphin Mesh (hernia repair), DERMAMATE/DURAMATE skin staplers, TACKSURE mesh tacker, POLYLOC polymer clips, Hemostax absorbable hemostat, Waxocare bone wax, surgical tapes, and customized suture kits for hernia, caesarean, OB Gyn, and orthopaedic procedures.

Differentiator

Problem solved

Functional benefit

Brands

• Dolphin Mesh: Surgical mesh brand for hernia repairs, including polypropylene mesh, composite mesh, dual mesh, and 3D mesh products
• Dermamate
• Duramate
• TACKSURE
• Hemostax
• Waxocare
• TEFLENE
• DURAFIBR
• Durabarb
• DURACRYL
• PETCRYL 910
• PETCRYL
• PROGUT
• DURACARE
• LINEX
• PROCARE
• SUTURA
• Steel Sutures
• POLYLOC
• Silene Mesh
• Ultralene Mesh
• Duolene Mesh
• Tiolene Mesh
• Monosolve Mesh

Products and services

• Antibacterials (Antibacterial Sutures) World's largest range of antibacterial sutures coated with Triclosan, providing broad-spectrum antimicrobial protection against Gram-positive, Gram-negative, drug-resistant, and biofilm-forming bacteria. Includes Durabarb Plus, Duracryl Plus, Petcryl Plus, Petcryl AB, Mono AB, and Monobarb Plus variants. Sold to hospitals, surgeons, and distributors.
• TEFLENE (PTFE Sutures) PTFE (Polytetrafluoroethylene) monofilament non-absorbable sutures; ultra-soft, high-density surgical suture ideal for oral and maxillofacial surgery. First and only Indian brand of PTFE sutures. Sold to hospitals, oral surgeons, and distributors.
• DURAFIBR (UHMWPE Sutures) Ultra-High Molecular Weight Polyethylene sutures up to 5x stronger than stainless steel on weight basis. White braided suture with blue tracer for improved visibility. Used in orthopaedic surgery, sports injury surgery, and sternum closure. Sold to hospitals and orthopaedic surgeons.
• Ligature Loop Sutures Pre-looped ligature sutures for minimally invasive surgical techniques including Catgut Loop, PDS Loop, and Polyglactin 910 Loop variants; includes plastic introducer for laparoscopic and open deep surgical applications. Sold to laparoscopic and general surgeons.
• Durabarb (Polydioxanone Barbed Sutures) Knotless wound closure device; sterile synthetic absorbable monofilament suture made from polydioxanone with barbs at 72 degree angle arranged in spiral manner. Available in unidirectional and bidirectional configurations. Used in oncology, geriatric, gynaecology, cosmetic surgery, urology, and laparoscopy. Sold to hospitals and specialist surgeons.
• PETCRYL 910 (Polyglactin 910 Sutures) Braided and coated synthetic absorbable suture composed of 90% Glycolide and 10% L-lactide. Retains 70% tensile strength at 14 days. Used for soft tissue approximation and ligation in general, ophthalmic, cardiovascular, orthopaedic, and GI surgeries. Sold to hospitals and surgical departments.
• PETCRYL 910 Fast (Polyglactin Rapid Sutures)

Quantifiable outcome

• Products reliably used in more than 75 million surgeries
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered minor and core.

• Medical Colleges and UniversitiesminorStrategic or Co-development PartnerPartnership with medical colleges and universities for product development feedback and clinical trials. Raw material suppliers from USA, UK, Germany, Japan, and Korea for specialized inputs.
• International DistributorscoreChannel Partner/ Reseller/ DistributorNetwork of distributors across 80+ countries including Africa, Asia, Europe, Australia, and South America. Partners include distributors in Nigeria, Ghana, Kenya, South Africa, China, Malaysia, Pakistan, Vietnam, Philippines, UK, Germany, Spain, Brazil, Peru, and many other nations.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Teleflex: Manufactures surgical sutures and ligation devices under its surgical solutions segment. Directly comparable in the sutures and wound closure category where Dolphin competes.
• Ethicon (Johnson & Johnson): Global market leader in surgical sutures and wound closure, holding the dominant share of branded sutures worldwide. Directly competes with Dolphin across absorbable, non-absorbable, and specialty sutures globally.
• B. Braun: Major surgical sutures and wound closure manufacturer with strong presence in Europe and emerging markets. Directly competes with Dolphin across the full suture portfolio including specialty and antibacterial sutures.
• Healthium Medtech: Indian medical device company (formerly Sutures India) specializing in surgical sutures and wound closure products. Most direct Indian-domestic competitor, sharing customers, regulatory pathways, and export markets with Dolphin.
• Meril Life Sciences: Indian medical device manufacturer with a surgical sutures portfolio alongside orthopedics, cardiology and diagnostics. Competes with Dolphin across India and in export markets in emerging geographies.
• Lotus Surgicals: Indian manufacturer specializing in surgical sutures and hernia mesh. Closely comparable in product mix, target customer (hospitals and surgeons), and emerging market export orientation.

Broad incumbents

• Medtronic: Acquired Covidien and now sells sutures, staplers, and wound closure products as part of a broad surgical portfolio. Competes with Dolphin in sutures and skin staplers, particularly in hospital contracts.
• Smith & Nephew: Global medical device company with wound closure and sutures offerings as part of a broader surgical and wound management portfolio. Competes with Dolphin in skin staplers and select suture categories.

Emerging players

• Futura Surgicals (Trinity Hospital Products): India-based competitor in absorbable sutures with similar export-led business model. Competes with Dolphin in price-sensitive suture segments across Africa and South-East Asia.
• Corza Medical: Specialty surgical and wound closure company (formerly parts of S&T and Covidien businesses) focused on sutures and microsurgery instruments. Comparable as a focused wound closure player targeting similar surgeon customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCEsF-O2YD2_6sS2z1HJ-MCA
• Facebookfacebook.com/DolphinSutures
• Instagraminstagram.com/dolphinsutures
• Xx.com/DolphinSutures
• LinkedInlinkedin.com/company/dolphinsutures

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dolphin Sutures